Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN110656147B reveals a high-yield biological method for steroid intermediates. Reduces costs and ensures supply chain stability for pharmaceutical manufacturing.
Patent CN112608970B reveals solvent-free biocatalysis for methylprednisolone intermediates. Achieves high conversion rates and scalable supply chain reliability for pharma manufacturing.
Patent CN101760496A details a biological dehydrogenation method for steroid intermediates using Arthrobacter simplex, offering a safer, high-yield alternative to toxic chemical processes for reliable supply chains.
Patent CN112899191B reveals a green route from phytosterol to bile acids, offering supply chain stability and cost efficiency for pharmaceutical manufacturers.
Patent CN112342261B reveals a green route for prednisone acetate using RSA. Discover cost-effective biocatalytic hydroxylation and oxidation for high-purity steroid production.
Patent CN107417705B reveals a metal-free S8-catalyzed route for imidazo[2,1-b]benzothiazole intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN109680032B reveals a high-yield microbial route for steroid hydroxylation. Discover cost-effective manufacturing and reliable supply chain solutions for pharmaceutical intermediates.
Patent CN110713510A reveals a novel resting cell fermentation route for steroid intermediates, offering significant cost reduction and improved purity for pharmaceutical manufacturing.
Discover the advanced biocatalytic route for Pregna-5,7-diene-3β,21-diol described in CN110846370A. Achieve high purity and cost reduction in steroid manufacturing with our scalable solutions.
Patent CN110951815A details a novel biocatalytic route for steroid intermediates. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN110592169B reveals a dual-strain microbial method for high-purity ADD production, offering significant cost reduction in pharmaceutical manufacturing and robust supply chain reliability.
Patent CN110628860A reveals advanced biotransformation for steroid intermediates. Enhances purity and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN119504564A details high-yield chiral synthesis. Offers supply chain stability and cost efficiency for pharmaceutical intermediates globally.
Patent CN117431292B reveals a high-yield one-step fermentation for 8DM. Discover cost reduction in steroid manufacturing and reliable supply chain solutions.
Discover a novel 3-step synthesis for Caspofungin intermediates via patent CN101648994B. Achieve higher purity, stable solids, and reduced manufacturing costs.
Patent CN110656146A reveals an oil-free method for DHEA production using protected phytosterol. This breakthrough offers high purity, reduced waste, and scalable manufacturing for pharmaceutical intermediates.
Patent CN116287086B reveals enzymatic water-phase synthesis for tazobactam. Offers cost reduction in pharmaceutical intermediates manufacturing and high-purity output.
Advanced preparation method for 2-methylpyridine-4-formic acid via patent CN110452165B. High purity, green process, and cost-effective supply chain solutions for global pharma.
Novel synthesis of antiviral entecavir using naphthyl silane protection. Reduces cost and improves scalability for pharmaceutical manufacturing.
Discover the patented CN101928214B method for synthesizing dexketoprofen trometamol. This report analyzes cost-effective octylglucamine resolution and industrial scalability for API manufacturers.